Lv12
34 积分 2025-11-24 加入
Cell therapy for liver disorders: past, present and future
2小时前
已完结
High prevalence of acquired cancer-related mutations in 146 human pluripotent stem cell lines and their differentiated derivatives
1天前
已完结
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
3天前
已完结
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
10天前
已完结
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
10天前
已完结
mRECIST for HCC: Performance and novel refinements
10天前
已完结
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
1个月前
已完结
Sex-specific prevalence and risk factors of metabolic-associated fatty liver disease among 75,570 individuals in eastern China
1个月前
已完结
Comparison of the identification and practicability of non-invasive diagnostic indicators under NAFLD, MAFLD and MASLD in China: a cross-sectional study
1个月前
已完结
Comparison of the identification and practicability of non-invasive diagnostic indicators under NAFLD, MAFLD and MASLD in China: a cross-sectional study
1个月前
已关闭
皖公网安备34019202002308
